Search Orphan Drug Designations and Approvals
-
Generic Name: | Atovaquone |
---|---|
Date Designated: | 03/16/1993 |
Orphan Designation: | Primary prophylaxis of HIV-infected persons at high risk for developing Toxoplasma gondii encephalitis. |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
GlaxoSmithKline, Inc. 5 Moore Drive PO Box 13398 Research Triangle Park, North Carolina 27709 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-